Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s Disease?
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder worldwide. Clinically, it is characterized by severe motor complications caused by a progressive degeneration of dopaminergic neurons (DAn) and dopamine loss. Current treatment is focused on mitigating the sym...
Main Authors: | Helena Vilaça-Faria, António J. Salgado, Fábio G. Teixeira |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/2/118 |
Similar Items
-
Exposure to blue light stimulates the proangiogenic capability of exosomes derived from human umbilical cord mesenchymal stem cells
by: Kun Yang, et al.
Published: (2019-11-01) -
Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson’s Disease
by: Michele d’Angelo, et al.
Published: (2020-07-01) -
Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson’s Disease
by: Fábio G. Teixeira, et al.
Published: (2020-01-01) -
Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities
by: Ali Hassanzadeh, et al.
Published: (2021-05-01) -
Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages
by: Kasra Asgarpour, et al.
Published: (2020-09-01)